Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690

NCT04046250 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucositis

Interventions

DRUG: TK-112690
DRUG: Placebo TK-112690

Sponsor

Tosk, Inc.

Collaborators

[object Object]